EUVIMEDEUVIMED entdecken
Vergleichsstudie

A Comparative Analysis of ADRs under Obeticholic Acid and Ursodeoxycholic Acid in Cholestatic Liver Diseases Using the FAERS Database

Meng Zhu, Linghui Tao, Feiye Zhu, Yongsheng Zhang

Drug Research · 01.11.2024 · 74 (09) · 464-474

DOI: 10.1055/a-2401-4700 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Drug Research, erschienen am 01.11.2024. Verfasst von Meng Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Zhejiang Chinese Medical University, Binjiang District, Hangzhou, Zhejiang Province, China. Hauptthemen laut MEDLINE: Ursodeoxycholic Acid, Databases, Factual, Chenodeoxycholic Acid. Die Arbeit nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this study was to compare the safety profiles of OCA and UDCA for the treatment of PBC using the FDA Adverse Event Reporting System database.

Methods

We extracted reports for OCA from 2016 to 2023 and UDCA from 2004 to 2023. Demographic details, adverse events (AEs), and concomitant medications were analyzed using descriptive statistics and signal detection methods.

Results

The most common for OCA were pruritus (1345 cases, ROR 20.96) and fatigue (528 cases, ROR 3.46). UDCA was more frequently associated with hepatocellular carcinoma (22 cases, ROR 16.37) and type I hypersensitivity reactions (11 cases, ROR 12.77). OCA was also linked to a higher frequency of constipation (161 cases, ROR 3.92) and increased blood alkaline phosphatase levels (145 cases, ROR 44.27).

Conclusion

This study reveals distinct safety profiles for OCA and UDCA in the treatment of PBC. OCA is associated with a higher frequency of pruritus, fatigue, constipation, and increased blood alkaline phosphatase levels, while UDCA is linked to hepatocellular carcinoma and type I hypersensitivity reactions. These findings support personalized treatment approaches based on individual patient characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ursodeoxycholic AcidDatabases, FactualChenodeoxycholic AcidHumansFemaleMaleMiddle AgedAdultPruritusAdverse Drug Reaction Reporting SystemsAgedLiver Cirrhosis, BiliaryUnited StatesCarcinoma, HepatocellularCholestasis

Substanzen

Ursodeoxycholic Acidobeticholic acidChenodeoxycholic Acid

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Zhejiang Chinese Medical University, Binjiang District, Hangzhou, Zhejiang Province, China.
  • Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Binjiang District, Hangzhou, Zhejiang Province, China.

Zitieren

APA

Zhu, M., Tao, L., Zhu, F., & Zhang, Y. (2024). A Comparative Analysis of ADRs under Obeticholic Acid and Ursodeoxycholic Acid in Cholestatic Liver Diseases Using the FAERS Database. Drug Research, 74(09), 464-474. https://doi.org/10.1055/a-2401-4700

Vancouver

Zhu M, Tao L, Zhu F, Zhang Y. A Comparative Analysis of ADRs under Obeticholic Acid and Ursodeoxycholic Acid in Cholestatic Liver Diseases Using the FAERS Database. Drug Research. 2024;74(09):464-474. doi:10.1055/a-2401-4700

BibTeX
@article{Zhu2024,
  author = {Zhu, Meng and Tao, Linghui and Zhu, Feiye and Zhang, Yongsheng},
  title = {A Comparative Analysis of ADRs under Obeticholic Acid and Ursodeoxycholic Acid in Cholestatic Liver Diseases Using the FAERS Database},
  journal = {Drug Research},
  year = {2024},
  volume = {74},
  number = {09},
  pages = {464--474},
  doi = {10.1055/a-2401-4700}
}
Kostenlos starten →